🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

8 recruiting trials

for Primary Open Angle Glaucoma or Ocular Hypertension

Efficacy and Safety of HUC3-637 in Patients With Primary Open Angle Glaucoma or Ocular Hypertension NCT07335211Phase 31 site📍 Seoul Huons Co., Ltd. · Tests: HUC3-637, HUC3-637-R A Prospective Study on the Efficacy of Direct Selective Laser Trabeculoplasty (DSLT) in Achieving >20% Intraocular Pressure (IOP) Reduction Without Medications at 6 Months in Naive, Untreated Glaucoma Patients NCT07076303n/a1 site📍 Plymouth Meeting Brian Shafer · Tests: Direct Selective Laser Trabuloplasty A Study to Evaluate Efficacy and Safety of YSBP Compared to Lumigan in Patients With Glaucoma or Ocular Hypertension NCT07661329Phase 322 sites📍 Beverly Hills📍 Inglewood📍 Newport Beach YS Life Science Co., Ltd. · Tests: Bimatoprost ophthalmic solution 0.01% YSBP, bimatoprost ophthalmic solution 0.01% (Lumigan®) [KJ-TFC-005] Phase 3 Study, Evaluate the Efficacy and Safety of TFC-003 in Patients With Primary Open-Angle Glaucoma or Ocular Hypertension NCT07662759Phase 31 site📍 Seongnam Kukje Pharma · Tests: TFC-003, TFC-003-R1, TFC-003-R2+TFC-003-R3 A Comparative Study of Intraocular Pressure Control Using Selective Laser Trabeculoplasty and Latanoprost as Initial Treatments for Primary Open Angle Glaucoma and Ocular Hypertension in Lagos State University Teaching Hospital NCT07310719NA1 site📍 Ikeja Lagos State Health Service Commission · Tests: Selective laser trabeculoplasty, Latanoprost (0.005%) Inflammatory Biomarkers in Ocular Surface in Primary Open Angle Glaucoma or Ocular Hypertension Under Topical Prostaglandins NCT05039684n/a1 site📍 Valladolid Instituto Universitario de Oftalmobiología Aplicada (Instit… DSLT for Reducing Medication in Glaucoma NCT07390890n/a1 site📍 Largo The Eye Institute of West Florida · Tests: Voyager DSLT REGN22530 for Adults With Primary Open Angle Glaucoma or Ocular Hypertension NCT07675824Phase 1, Phase 21 site📍 Deerfield Beach Regeneron Pharmaceuticals · Tests: REGN22530
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy